SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-24-000023
Filing Date
2024-05-06
Accepted
2024-05-06 16:56:22
Documents
99
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20240331.htm   iXBRL 10-Q 974223
2 EX-31.1 exhibit311-q12024.htm EX-31.1 11014
3 EX-31.2 exhibit312-q12024.htm EX-31.2 10945
4 EX-32.1 exhibit321-q12024.htm EX-32.1 5910
5 EX-32.2 exhibit322-q12024.htm EX-32.2 6152
  Complete submission text file 0001808665-24-000023.txt   6548439

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20240331.xsd EX-101.SCH 52711
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20240331_cal.xml EX-101.CAL 92667
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20240331_def.xml EX-101.DEF 254085
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20240331_lab.xml EX-101.LAB 548006
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20240331_pre.xml EX-101.PRE 414913
103 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20240331_htm.xml XML 993280
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 24918383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)